胰岛素注射器市场规模、份额及成长分析（按註射器尺寸、疾病类型、最终用途、分销管道和地区）－2025-2032 年产业预测

2023 年全球胰岛素注射器市场规模为 17 亿美元，预计将从 2024 年的 17.7 亿美元成长到 2032 年的 24.6 亿美元，预测期间（2025-2032 年）的复合年增长率为 4.2%。

全球胰岛素注射器市场正在经历显着增长，因为糖尿病，特别是 2 型糖尿病的盛行率正以惊人的速度增长，而久坐的生活方式、不健康的饮食、都市化和不断上升的肥胖率都是导致这一现象的根源。国际糖尿病联盟预测，到 2045 年，成年糖尿病患者人数将从 2021 年的 5.37 亿激增至 7.83 亿，这将对有效的胰岛素输送系统产生越来越大的需求。随着诺和诺德等大型製药公司从传统的人类胰岛素笔转向利润更高的 GLP-1 受体促效剂，许多患者，尤其是中低收入国家的患者，面临着越来越少的负担得起的选择。因此，传统胰岛素注射器的使用再次兴起，尤其是在非技术医疗环境中，这进一步刺激了市场需求。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 二次资料和一次资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态与展望

• 市场概览
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

关键市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024年）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 定价分析
• 监管格局
• 案例研究
• 技术分析

胰岛素注射器市场规模（以注射器尺寸）

• 市场概览
• 3/10 CC注射器（0.3毫升）
• 1/2 CC注射器（0.5毫升）
• 1 CC注射器（1毫升）
• 其他的

胰岛素注射器市场规模（依疾病类型划分）

• 市场概览
• 1型糖尿病
• 2型糖尿病

胰岛素注射器市场规模（依最终用途）

• 市场概览
• 医院和诊所
• 居家照护环境
• 其他的

胰岛素注射器市场规模（按分销管道）

• 市场概览
• 医院药房
• 零售药局
• 网路药局

胰岛素注射器市场规模（以针头长度）

• 市场概览
• 短的
• 中等的
• 长的

胰岛素注射器市场规模（依产品类型）

• 市场概览
• 标准胰岛素注射器
• 安全胰岛素注射器

胰岛素注射器市场规模

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2024年）
• 主要企业简介
  • 公司详情
  • 产品系列分析
  • 公司分部份额分析
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• Novo Nordisk A/S（Denmark）
• Eli Lilly and Company（US）
• Sanofi SA（France）
• Becton, Dickinson and Company（BD）（US）
• Terumo Corporation（Japan）
• Cardinal Health Inc.（US）
• Medtronic plc（Ireland）
• Abbott Laboratories（US）
• Nipro Corporation（Japan）
• Biocon Ltd.（India）
• Hindustan Syringes & Medical Devices Ltd.（India）
• B. Braun Melsungen AG（Germany）
• Ypsomed Holding AG（Switzerland）
• Stevanato Group SpA（Italy）
• Schott Pharma AG & Co. KGaA（Germany）
• ApiJect Systems Corporation（US）
• Teleflex Incorporated（US）
• Owen Mumford Ltd.（UK）
• Allison Medical Inc.（US）

结论和建议

Global Insulin Syringes Market size was valued at USD 1.7 billion in 2023 and is poised to grow from USD 1.77 billion in 2024 to USD 2.46 billion by 2032, growing at a CAGR of 4.2% during the forecast period (2025-2032).

The global insulin syringes market is experiencing significant growth due to the alarming rise in diabetes prevalence, particularly type 2 diabetes, fueled by sedentary lifestyles, unhealthy diets, urbanization, and increasing obesity rates. The International Diabetes Federation projects that the adult diabetes population will surge from 537 million in 2021 to 783 million by 2045, creating a heightened demand for effective insulin delivery systems. As major pharmaceutical companies like Novo Nordisk shift focus from traditional human insulin pens to higher-margin GLP-1 receptor agonists, many patients, particularly in low- and middle-income countries, are left with fewer affordable options. Consequently, there's a resurgence in the use of conventional insulin syringes, especially in healthcare settings lacking advanced technologies, further boosting market demand.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Insulin Syringes market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Insulin Syringes Market Segments Analysis

Global Insulin Syringes Market is segmented by Syringe Size, Disease Type, End-Use, Distribution Channel, Needle Length, Product Type and region. Based on Syringe Size, the market is segmented into 3/10 CC Syringe (0.3ml), 1/2 CC Syringe (0.5ml), 1 CC Syringe (1ml) and Others. Based on Disease Type, the market is segmented into Type 1 Diabetes and Type 2 Diabetes. Based on End-Use, the market is segmented into Hospitals & Clinics, Homecare Settings and Others. Based on Distribution Channel, the market is segmented into Hospital Pharmacies, Retail Pharmacies and Online Pharmacies. Based on Needle Length, the market is segmented into Short, Medium and Long. Based on Product Type, the market is segmented into Standard Insulin Syringes and Safety Insulin Syringes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Insulin Syringes Market

The global increase in the elderly population is contributing significantly to the rise in diabetes prevalence, resulting in heightened insulin usage. As age-related diabetes cases continue to climb, the demand for insulin syringes is steadily on the rise. This trend is driving market expansion, as effective and regular insulin administration becomes increasingly essential for managing the health of diabetic patients. Consequently, the urgent need for insulin syringes as a critical tool in diabetes care is a primary factor propelling growth in the global insulin syringes market.

Restraints in the Global Insulin Syringes Market

A significant constraint within the global insulin syringes market arises from patients' reluctance to initiate or adhere to insulin therapy, primarily due to fear of needles and the discomfort associated with injections. This apprehension leads to infrequent use of syringes, which hinders overall market growth. The issue of patient compliance remains critical in effective diabetes management, and when individuals are deterred from regular insulin usage, it creates barriers to market expansion. Addressing these concerns is essential to increase acceptance and utilization of insulin syringes, ultimately improving diabetes care and enhancing market potential.

Market Trends of the Global Insulin Syringes Market

The Global Insulin Syringes market is witnessing a notable trend towards miniaturized syringes, specifically 0.5 ml variants, driven by the growing demand from pediatric patients and individuals with Type 1 diabetes. These smaller syringes enhance dosing accuracy and provide a more comfortable experience for users, addressing the critical need for improved patient compliance. As more healthcare providers and patients recognize the benefits of these compact devices, manufacturers are increasingly focusing on innovation to meet this demand. This shift is expected to significantly influence market dynamics, fostering growth and expanding the availability of user-friendly insulin delivery solutions worldwide.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies
• Technological Analysis

Global Insulin Syringes Market Size by Syringe Size & CAGR (2025-2032)

• Market Overview
• 3/10 CC Syringe (0.3ml)
• 1/2 CC Syringe (0.5ml)
• 1 CC Syringe (1ml)
• Others

Global Insulin Syringes Market Size by Disease Type & CAGR (2025-2032)

• Market Overview
• Type 1 Diabetes
• Type 2 Diabetes

Global Insulin Syringes Market Size by End-Use & CAGR (2025-2032)

• Market Overview
• Hospitals & Clinics
• Homecare Settings
• Others

Global Insulin Syringes Market Size by Distribution Channel & CAGR (2025-2032)

• Market Overview
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Global Insulin Syringes Market Size by Needle Length & CAGR (2025-2032)

• Market Overview
• Short
• Medium
• Long

Global Insulin Syringes Market Size by Product Type & CAGR (2025-2032)

• Market Overview
• Standard Insulin Syringes
• Safety Insulin Syringes

Global Insulin Syringes Market Size & CAGR (2025-2032)

• North America (Syringe Size, Disease Type, End-Use, Distribution Channel, Needle Length, Product Type)
  • US
  • Canada
• Europe (Syringe Size, Disease Type, End-Use, Distribution Channel, Needle Length, Product Type)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Syringe Size, Disease Type, End-Use, Distribution Channel, Needle Length, Product Type)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Syringe Size, Disease Type, End-Use, Distribution Channel, Needle Length, Product Type)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Syringe Size, Disease Type, End-Use, Distribution Channel, Needle Length, Product Type)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Novo Nordisk A/S (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eli Lilly and Company (U.S.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi S.A. (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (BD) (U.S.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardinal Health Inc. (U.S.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (U.S.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nipro Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biocon Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hindustan Syringes & Medical Devices Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun Melsungen AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ypsomed Holding AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stevanato Group S.p.A. (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Schott Pharma AG & Co. KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ApiJect Systems Corporation (U.S.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teleflex Incorporated (U.S.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Owen Mumford Ltd. (U.K.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Allison Medical Inc. (U.S.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations